GANANCIA PONDERAL DESPUES DE LA CIRUGIA FUNCIONAL EN LA ENFERMEDAD DE PARKINSON

(especial para SIIC © Derechos reservados)
La cirugía funcional de la EP provoca un aumento ponderal que es benigno en la mayoría de casos. La reducción del gasto energético con respecto a la situación prequirúrgica podría ser responsable de este fenómeno.
gironell9.jpg Autor:
Alexandre Gironell,
Columnista Experto de SIIC
Artículos publicados por Alexandre Gironell,
Coautores
Berta Pascual-Sedano*  Jaime Kulisevsky.** 
Licenciado en Medicina y Cirugía. Servicio de Neurología. Hospital de la Santa Creu i Sant Pau. Barcelona. Catalunya.*
Doctor en Medicina y Cirugía Servicio de Neurología. Hospital de la Santa Creu i Sant Pau. Barcelona. Catalunya**
Recepción del artículo
4 de Marzo, 2004
Primera edición
4 de Junio, 2004
Segunda edición, ampliada y corregida
7 de Junio, 2021

Resumen
Objetivo: Realizamos un estudio prospectivo para determinar las posibles causas de la ganancia ponderal después de la cirugía funcional de la enfermedad de Parkinson (EP). Métodos: Se estudiaron 27 pacientes con un seguimiento posoperatorio de 12 meses. Se relacionó el aumento ponderal con los cambios de la situación motora, dosis de levodopa, discinesias, disfagia y estado de ánimo. Los pacientes completaron un cuestionario sobre la gravedad y las causas del aumento ponderal. Resultados: Se registró un aumento ponderal en 26 pacientes (media 4.7 kg). Se halló una correlación significativa con la mejora de la escala de discinesias (AIMS) (r = 0.461, p = 0.023) y de la parte motora de la escala UPDRS (r = 0.479; p = 0.028), así como una correlación inversa significativa con el peso inicial del paciente (r = -0.399, p = 0.050). La ganancia ponderal fue superior con la cirugía palidal bilateral respecto de la unilateral (p = 0.021). La mayoría de los pacientes consideraron el aumento ponderal como un efecto adverso leve y secundario a la mejora de las discinesias. Conclusiones: La cirugía funcional de la EP provoca un aumento ponderal que es benigno en la mayoría de casos. La reducción del gasto energético con respecto a la situación prequirúrgica podría ser responsable de este fenómeno.

Palabras clave
Enfermedad de Parkinson, peso. Palidotomía, estimulación cerebral profunda, subtálamo


Artículo completo

(castellano)
Extensión:  +/-5.83 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Abstract
Background: The origin of weight gain after functional surgery for Parkinson's disease (PD) is incompletely known. We have done a prospective study to determine the possible causes of weight gain after pallidal and subthalamic surgery. Methods: Twenty-seven patients were studied with a follow-up of 12 months. The relationship between weight gain and changes in motor situation, levodopa dosage, dyskinesias, dysphagia and mood state were analized. The patients filled a questionaire about the severity and etiology of weight gain. Results: Weight gain was noted in 26 patients (mean of 4.7 kg). It was found a significant correlation between weight gain and improvement of dyskinesias (AIMS) (r = 0.461, p = 0.023), the scores of the UPDRS part III, (r = 0.479; p = 0.028), and a significant inverse correlation with the pre-operative weight of the patient (r = -0.399, p = 0.050). Weight gain was most pronounced with bilateral than unilateral pallidal surgery (p = 0.021). The majority of patients referred weight gain as an slight adverse event and secondary to the improvement of dyskinesias. Conclusion: Functional surgery for PD, independently of the surgical target, provokes weight gain which is benign in the majority of cases. Reduction of energy expenditure with respect to the pre-operative situation would be the responsible of that phenomenon.

Key words
Parkinson's disease, weight, pallidotomy, deep brain stimulation, subthalamus


Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Neurología
Relacionadas: Endocrinología y Metabolismo, Medicina Interna, Neurocirugía, Nutrición, Salud Mental



Comprar este artículo
Extensión: 5.83 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Gironell, Alexandre
Bibliografía del artículo
  1. Abbott RA, Cox M, Markus H, Tomkins A. Diet, body size and micronutrient status in Parkinson's disease. Eur J Clin Nutr 1992;46:879-884.
  2. Davies K, King D, Danies H. A study of the nutritional status of elderly patients with Parkinson's disease. Age Aging 1994;23:142-145.
  3. Beyer P, Palarnino M, Michalek D, Busenbark K, Koller WC. Weight change and body composition in patients with Parkinson's disease. J Am Diet Assoc 1995;95:979-983.
  4. Jankovic J, Wooten M, Van der Linden C, Jansson B. Low body weight in Parkinson's disease. Sout Med J 1992;85:251-4.
  5. Markus HS,, Tomkins AM, Stern GM. Increased prevalence of undernutrition in Parkinson's disease and its relationship to clinical disease parameters. J Neural Transm 1993;5:117-25.
  6. Lang A, Lozano A,Tasker R, Duff J, Saint-Cyr J, Trépanier L. Neuropsychologic and bahavioral changes and weight gain after medial pallidotomy. Ann Neurol 1997; 41:834-835.
  7. Ondo WG, Ben-Aire L, Jankovic J, Lai E, Contant C, Grossman R. Weight gain following unilateral pallidotomy in Parkinson's disease. Acta Neurol Scand 2000;101:70-84.
  8. Fahn S, Elton RL,"Members of the UPDRS Development Committee. Unified Parkinson's disease Rating Scale". En: Fahn S; Marsden CD, Calne DB, Goldstein M, editores. Recent developments in Parkinson's disease, vol 2. Florham Park, NJ: Macmillan Health Care Information, 1987; 153-164.
  9. Langston JW, Widner H, Goetz CG, et al (CAPIT Committee). Core Assessment Program for Intracerebral Transplantations (CAPIT). Mov Disord 1992; 7: 2-13.
  10. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-1387.
  11. Sweet RA, DeSensi EG, Zubenko GS. Reliability and applicability of movement disorder rating scales in the elderly. J Neuropsychiatry Clin Neurosci 1993;5:56-60.
  12. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961: 4:53-63.
  13. Barichella M, Marczewska AG, Mariani C, Landi A, Vairo A, Pezzoli G. Body weight gain rate in patients with Parkinson's disease and deep brain stimulation. Mov Disord 2003; 18:1337-1340.
  14. Markus H, Cox M, Tomkins A. Raised resting energy expenditure in Parkinson's disease an its relationship to muscle rigidity. Clin Sci 1992;83:199-204.
  15. Levi S, Cox M, Lugon M, Hodkinson M, Tomkins A. Increased energy expenditure in Parkinson's disease. BMJ 1990;301:1256-1257.
  16. Toth M, Fishman P, Poehlman E. Free living daily energy expenditure in patients with Parkinson's disease. Neurology 1997; 48:88-91.
  17. Edwards L, Quigley E, Pfeifer R. Gastointestinal dysfunction in Parkinson's disease. Neurology 1992;42:726-732.
  18. Gorell JM, Johnson CC, Rybicki BA, Peterson EC. Nutrient intake in Parkinson's disease: a case control study. Mov Disord 1994;9(suppl 1):75.
  19. Hellenbrand W, Seidler A, Boeing H, Robra BP, Viregge P, Nischan P, et al. Diet and Parkinson's disease: a possible role for past intake of specific foods and food groups. Results from a self-administered food frequency questionnaire in a case control study. Neurology 1996;47:636-643.
  20. Rosenbaum M, Leibgel R, Hirsh JH. Obesity. N Engl J Med 1997;337:396-407.
  21. Corbett S, Keesey R. Energy balance of rats with lateral hypothalamic lesions. Am J Physiol 1982;242:E273-E279.
  22. Harris R. Role of set point theory in regulation of body weight. FASEB J 1990;4:3310-3318.
  23. Javoy-Agid F, Ruberg M, Pique L, Bertagna X, Taquet H, Studler JM, et al. Biochemistry of the hypothalamus in Parkinson's disease. Neurology 1984; 34:672-675.
  24. Langston JK, Forno LS. The hypothalamus in Parkinson's disease. Ann Neurol 1978:3:129-133.
  25. Wakabayashi K, Takahashi H. Neuropathology of the autonomic nervous system in Parkinson's disease. Eur Neurol 1997;38(suppl 2):2-7.
  26. Kim R, Nakano K, Jayaraman A, Carpenter MB. Projections of the globus pallidusand adjacent structures: an autoradiographic study in the monkey. J Comp Neurol 1976;169:263-282.
  27. Nauta W, Mehler W. Projections of the lentiform nucleus in the monkey. Brain Res 1966;1:3-42.
  28. Krauss J, Desaloms M, Lai EC, King DE, Jankovic J, Grossman RG. Microelectrode-guided posteroventral pallidotomy for treatment of Parkinson's disease: postoperative magnetic resonance imaging analysis. J Neurosurg 1997;87:358-367.
  29. Janokovic J, Hamilton WJ, Grossman RG. Thalamic surgery for movement disorders. En: Obeso JA, DeLong MR, Marsden CD, editores. The basal ganglia and new surgical approaches for Parkinson's disease. Advances in Neurolgy, vol. 74. Philadelphia: Lippincott-Raven, 1997; 221-233.
  30. Taylor DJ, Krige D, Barnes PRJ, Kemp GJ, Carroll MT, Mann UM, et al. A 31P magnetic resonance spectroscopy study of mitochondrial funtion in skeletal muscle of patients with Parkinson's disease. J Neurol Sci 1994:125:77-81.
  31. Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF. Assessment of energy metabolism defects in Huntington's disease and possible therapy with Q10. Ann Neurol 1997;41:160-5.
  32. Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazszouz A, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998; 121: 451-457.

 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Home

Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008